Prosecution Insights
Prosecution Insights
28 pending office actions • 17 clients • 24 examiners • 19 art units • 0 of 28 (0%) have an AI response strategy ready • 14 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 28 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 28 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 17 (61%) |
| §102 only | 4 (14%) |
| §112 only | 2 (7%) |
| No statute on record | 5 (18%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, BRYAN | 2 | 28.7% | +36.7% |
| WEBB, WALTER E | 2 | 46.4% | +18.6% |
| MARTIN, KEVIN STEPHEN | 2 | 75.9% | +23.6% |
| FIEBIG, RUSSELL G | 2 | 62.7% | +25.8% |
| BLANCHETTE, JOSHUA B | 1 | 46.9% | +30.6% |
| BRANDSEN, BENJAMIN MICHAEL | 1 | 61.5% | +17.0% |
| SCOTLAND, REBECCA LYNN | 1 | 0.0% | +0.0% |
| KOROTCHKINA, LIOUBOV G | 1 | 28.0% | +59.9% |
| MCCLAIN, STARFARI TESHAWN | 1 | 92.9% | +8.0% |
| GALSTER, SAMUEL LEONARD | 1 | 53.8% | +39.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18338927 | SOLID CATALYST COMPOSITION FOR ORGANIC WASTE TREATMENT, MANUFACTURING METHOD THEREOF AND USE THEREOF | MCCLAIN, STARFARI TESHAWN | 84d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | KOROTCHKINA, LIOUBOV G | 49d overdue |
| 17193141 | Consumable Product Comprising Malted Wheat | KIM, BRYAN | 31d overdue |
| 18354129 | COSMETIC COMPOSITION | SCOTLAND, REBECCA LYNN | 4d overdue |
| 18558029 | A METHOD AND A SYSTEM FOR MANUFACTURING A PROTEIN-RICH BIOMASS COMPRISNG EDIBLE FILAMENTOUS FUNGUS | KIM, BRYAN | 42d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17997041 | USES OF ANTRODIA CINNAMOMEA EXTRACT IN MANUFACTURING PRODUCTS FOR REDUCING EXPRESSION AND TREATING ASSOCIATED DISEASES OF ANGIOTENSIN CONVERTING ENZYME 2 | FIEBIG, RUSSELL G | 161d overdue |
| 18502426 | ELECTRICAL CONDITION DATA MANAGEMENT APPARATUS, PROGRAM, AND METHOD | BLANCHETTE, JOSHUA B | 91d overdue |
| 18256080 | Prebiotic Composition for Butyric Acid Bacteria | GALSTER, SAMUEL LEONARD | 70d overdue |
| 18550853 | Prevention and Treatment of Periodontal and Peri-Implant Disease | BRANDSEN, BENJAMIN MICHAEL | 49d overdue |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | KOROTCHKINA, LIOUBOV G | 49d overdue |
| 17910175 | A Consumable Product Comprising Malted Cereals for Promoting Recovery at Physical Activity | FIEBIG, RUSSELL G | 35d overdue |
| 18155281 | METHODS OF EXTENDING LIFESPAN BY ADMINISTERING FERROPTOSIS INHIBITORS | MARTIN, KEVIN STEPHEN | 31d overdue |
| 17438158 | Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders | MARTIN, KEVIN STEPHEN | 31d overdue |
| Art Unit | Apps |
|---|---|
| 1653 | 4 |
| 1624 | 3 |
| 1792 | 2 |
| 1693 | 2 |
| 1612 | 2 |
| 1655 | 2 |
| 3684 | 1 |
| 1615 | 1 |
| 1736 | 1 |
| 1631 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18502426 | ELECTRICAL CONDITION DATA MANAGEMENT APPARATUS, PROGRAM, AND METHOD | Ajinomoto Co., Inc. | BLANCHETTE, JOSHUA B | 3684 | §103 | Non-Final OA | 91d overdue | Pending | Nov 06, 2023 |
| 18558029 | A METHOD AND A SYSTEM FOR MANUFACTURING A PROTEIN-RICH BIOMASS COMPRISNG EDIBLE FILAMENTOUS FUNGUS | Millow Holding AB | KIM, BRYAN | 1792 | §112 | Non-Final OA | 42d | Pending | Oct 30, 2023 |
| 18550853 | Prevention and Treatment of Periodontal and Peri-Implant Disease | Labrida AS | BRANDSEN, BENJAMIN MICHAEL | 1693 | §102 | Non-Final OA | 49d overdue | Pending | Sep 15, 2023 |
| 18354129 | COSMETIC COMPOSITION | Ajinomoto Co., Inc. | SCOTLAND, REBECCA LYNN | 1615 | §103 | Non-Final OA | 4d overdue | Pending | Jul 18, 2023 |
| 18350982 | METHOD FOR PRODUCING PHYTOSPHINGOSINE OR PHYTOCERAMIDE | Danstar Ferment AG | KOROTCHKINA, LIOUBOV G | 1653 | Other | Non-Final OA | 49d overdue | Pending | Jul 12, 2023 |
| 18338927 | SOLID CATALYST COMPOSITION FOR ORGANIC WASTE TREATMENT, MANUFACTURING METHOD THEREOF AND USE THEREOF | Tetanti Agribiotech Inc. | MCCLAIN, STARFARI TESHAWN | 1736 | §103 | Non-Final OA | 84d | Pending | Jun 21, 2023 |
| 18256080 | Prebiotic Composition for Butyric Acid Bacteria | Morinaga Milk Industry Co., Ltd. | GALSTER, SAMUEL LEONARD | 1693 | §102 | Non-Final OA | 70d overdue | Pending | Jun 06, 2023 |
| 18250643 | Anti-Microbial Skin-Care Composition Comprising Beta-Glucan and Natural Oil | Lantmännen Oats AB | WEBB, WALTER E | 1612 | §103 | Non-Final OA | 15d overdue | Pending | Apr 26, 2023 |
| 18170671 | PHARMACEUTICAL COMPOSITION COMPRISING MODIFIED NATURAL KILLER CELLS AND ANTIGEN-SPECIFIC T CELLS, MANUFACTURING METHOD THEREOF, AND METHOD OF USING THE SAME | National Yang Ming Chiao Tung University | GRABER, JAMES J | 1631 | §112 | Non-Final OA | 12d | Pending | Feb 17, 2023 |
| 18155281 | METHODS OF EXTENDING LIFESPAN BY ADMINISTERING FERROPTOSIS INHIBITORS | Collaborative Medicinal Development, LLC | MARTIN, KEVIN STEPHEN | 1624 | §102 | Non-Final OA | 31d overdue | Pending | Jan 17, 2023 |
| 18065167 | METHOD FOR INDUCING ENVIRONMENTAL STRESS TOLERANCE IN PLANTS | Ajinomoto Co., Inc. | LIU, SUE XU | 1616 | Other | Non-Final OA | 12d | Pending | Dec 13, 2022 |
| 17999081 | Use of SAA, rSAA or inhibitors of SAA in the treatment of dysregulated inflammation | Lika Antisepsis Gbr | JUEDES, AMY E | 1644 | §103 | Non-Final OA | 17d overdue | Pending | Nov 17, 2022 |
| 17998559 | DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF | Hunilife Biotechnology, Inc. | HAQ, SHAFIQUL | 1678 | §103 | Non-Final OA | 72d | Pending | Nov 11, 2022 |
| 17997041 | USES OF ANTRODIA CINNAMOMEA EXTRACT IN MANUFACTURING PRODUCTS FOR REDUCING EXPRESSION AND TREATING ASSOCIATED DISEASES OF ANGIOTENSIN CONVERTING ENZYME 2 | Alps Biotech Co., Ltd. | FIEBIG, RUSSELL G | 1655 | §103 | Non-Final OA | 161d overdue | Pending | Oct 25, 2022 |
| 17947596 | L-GLUTAMATE OXIDASE MUTANT | Ajinomoto Co., Inc. | EIX, EMILY FAY | 1653 | §103 | Final Rejection | 22d | Pending | Sep 19, 2022 |
| 17910175 | A Consumable Product Comprising Malted Cereals for Promoting Recovery at Physical Activity | LANTMÄNNEN FUNCTIONAL FOODS AB | FIEBIG, RUSSELL G | 1655 | §103 | Final Rejection | 35d overdue | Pending | Sep 08, 2022 |
| 17939570 | Liquid Composition for Cleaning, Sanitizing and/or Disinfecting | Corticalis AS | WEBB, WALTER E | 1612 | §103 | Final Rejection | 26d overdue | Pending | Sep 07, 2022 |
| 17799466 | A PROCESS FOR THE PRODUCTION OF A BAKED PRODUCT WITHOUT ADDITION OF SUGAR | Lantmännen Unibake Holding A/S | TRAN, LIEN THUY | 1793 | §103 | Final Rejection | 73d overdue | Pending | Aug 12, 2022 |
| 17730360 | BENZALDEHYDE PRODUCTION METHOD | Ajinomoto Co., Inc. | LANDAU, SHARMILA GOLLAMUDI | 1653 | §102 | Non-Final OA | 96d overdue | Pending | Apr 27, 2022 |
| 17767232 | Calreticulin for Treating or Preventing an Angiogenic Eye Disease | Uab Baltymas | REYNOLDS, FRED H | 1658 | §103 | Non-Final OA | 141d overdue | Pending | Apr 07, 2022 |
| 17714537 | Modified Phenylalanine Dehydrogenase | Ajinomoto Co., Inc. | ZINGARELLI, SANDRA | 1653 | §103 | Non-Final OA | 232d overdue | Pending | Apr 06, 2022 |
| 17713804 | Surfactant and Composition | Ajinomoto Co., Inc. | ISNOR, ALEXANDRA NICOLE | 1611 | §103 | Final Rejection | 17d overdue | Pending | Apr 05, 2022 |
| 17639649 | A NOVEL POLYMORPH AND USES THEREOF | Procypra Therapeutics, LLC | BRAUN, MADELINE E | 1624 | Other | Non-Final OA | 163d overdue | Pending | Mar 02, 2022 |
| 17633386 | Composition for Babies and Infants for Improving Memory Ability in Childhood | Morinaga Milk Industry Co., Ltd. | OGUNBIYI, OLUWATOSIN A | 1645 | §103 | Non-Final OA | 42d overdue | Pending | Feb 07, 2022 |
| 17611312 | COMPOSITION | Morinaga Milk Industry Co., Ltd. | EDWARDS, JESSICA FAYE | 1657 | §103 | Non-Final OA | 5d | Pending | Nov 15, 2021 |
| 17438158 | Heteroaromatic and Heterobicyclic Aromatic Derivatives for the Treatment of Ferroptosis-Related Disorders | Collaborative Medicinal Development, LLC | MARTIN, KEVIN STEPHEN | 1624 | Other | Non-Final OA | 31d overdue | Pending | Sep 10, 2021 |
| 17193141 | Consumable Product Comprising Malted Wheat | LANTMÄNNEN FUNCTIONAL FOODS AB | KIM, BRYAN | 1792 | §103 | Non-Final OA | 31d overdue | Pending | Mar 05, 2021 |
| 16985492 | PERIODONTAL DISEASE TREATMENT | Straumann Holding AG | EIDE, HEIDI MARIE | 3772 | Other | Non-Final OA | 12d | Pending | Aug 05, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial